EGFR and nasopharyngeal carcinoma: Since significant heterogeneity was detected in the meta-analysis of the studies on the association of EGFR expression with OS and DMFS in nasopharyngeal carcinoma patients, we performed sensitivity analysis to see if the exclusion of any study would impact the synthesized results of HR and 95% CI.